These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone. Dwivedi Y; Rizavi HS; Pandey GN Neuroscience; 2006; 139(3):1017-29. PubMed ID: 16500030 [TBL] [Abstract][Full Text] [Related]
6. Physical exercise and antidepressants enhance BDNF targeting in hippocampal CA3 dendrites: further evidence of a spatial code for BDNF splice variants. Baj G; D'Alessandro V; Musazzi L; Mallei A; Sartori CR; Sciancalepore M; Tardito D; Langone F; Popoli M; Tongiorgi E Neuropsychopharmacology; 2012 Jun; 37(7):1600-11. PubMed ID: 22318196 [TBL] [Abstract][Full Text] [Related]
7. Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Dias BG; Banerjee SB; Duman RS; Vaidya VA Neuropharmacology; 2003 Sep; 45(4):553-63. PubMed ID: 12907316 [TBL] [Abstract][Full Text] [Related]
8. The effects of desipramine, fluoxetine, or tianeptine on changes in bulbar BDNF levels induced by chronic social instability stress and inflammation. Nowacka-Chmielewska MM; Kasprowska D; Paul-Samojedny M; Bielecka-Wajdman AM; Barski JJ; Małecki A; Obuchowicz E Pharmacol Rep; 2017 Jun; 69(3):520-525. PubMed ID: 28359918 [TBL] [Abstract][Full Text] [Related]
9. Differential behavioral and neurochemical effects of exercise, reboxetine and citalopram with the forced swim test. Arunrut T; Alejandre H; Chen M; Cha J; Russo-Neustadt A Life Sci; 2009 Apr; 84(17-18):584-9. PubMed ID: 19302801 [TBL] [Abstract][Full Text] [Related]
10. Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants. Larsen MH; Hay-Schmidt A; Rønn LC; Mikkelsen JD Eur J Pharmacol; 2008 Jan; 578(2-3):114-22. PubMed ID: 17950272 [TBL] [Abstract][Full Text] [Related]
11. Chronic treatment with desipramine and fluoxetine modulate BDNF, CaMKKalpha and CaMKKbeta mRNA levels in the hippocampus of transgenic mice expressing antisense RNA against the glucocorticoid receptor. Vinet J; Carra S; Blom JM; Brunello N; Barden N; Tascedda F Neuropharmacology; 2004 Dec; 47(7):1062-9. PubMed ID: 15555640 [TBL] [Abstract][Full Text] [Related]
12. Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments. Balu DT; Hoshaw BA; Malberg JE; Rosenzweig-Lipson S; Schechter LE; Lucki I Brain Res; 2008 May; 1211():37-43. PubMed ID: 18433734 [TBL] [Abstract][Full Text] [Related]
13. Chronic administration of the delta opioid receptor agonist (+)BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats. Torregrossa MM; Folk JE; Rice KC; Watson SJ; Woods JH Psychopharmacology (Berl); 2005 Nov; 183(1):31-40. PubMed ID: 16220339 [TBL] [Abstract][Full Text] [Related]
14. Nucleocytoplasmic export of HDAC5 and SIRT2 downregulation: two epigenetic mechanisms by which antidepressants enhance synaptic plasticity markers. Muñoz-Cobo I; Erburu MM; Zwergel C; Cirilli R; Mai A; Valente S; Puerta E; Tordera RM Psychopharmacology (Berl); 2018 Oct; 235(10):2831-2846. PubMed ID: 30091005 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of brain-derived neurotrophic factor (BDNF) splice variant translation using a novel drug screening assay: a "quantitative code". Vaghi V; Polacchini A; Baj G; Pinheiro VL; Vicario A; Tongiorgi E J Biol Chem; 2014 Oct; 289(40):27702-13. PubMed ID: 25074925 [TBL] [Abstract][Full Text] [Related]
16. Clinically relevant doses of fluoxetine and reboxetine induce changes in the TrkB content of central excitatory synapses. Wyneken U; Sandoval M; Sandoval S; Jorquera F; González I; Vargas F; Falcon R; Monari M; Orrego F Neuropsychopharmacology; 2006 Nov; 31(11):2415-23. PubMed ID: 16554746 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of BDNF promoters I, II and IV reveals that serotonin and norepinephrine input is sufficient for transcription activation. Musazzi L; Rimland JM; Ieraci A; Racagni G; Domenici E; Popoli M Int J Neuropsychopharmacol; 2014 May; 17(5):779-91. PubMed ID: 24451568 [TBL] [Abstract][Full Text] [Related]
18. Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Cryan JF; Page ME; Lucki I Psychopharmacology (Berl); 2005 Nov; 182(3):335-44. PubMed ID: 16001105 [TBL] [Abstract][Full Text] [Related]
19. Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells. Garzon DJ; Fahnestock M J Neurosci; 2007 Mar; 27(10):2628-35. PubMed ID: 17344400 [TBL] [Abstract][Full Text] [Related]
20. Paroxetine rapidly modulates the expression of brain-derived neurotrophic factor mRNA and protein in a human glioblastoma-astrocytoma cell line. Angelucci F; Croce N; Spalletta G; Dinallo V; Gravina P; Bossù P; Federici G; Caltagirone C; Bernardini S Pharmacology; 2011; 87(1-2):5-10. PubMed ID: 21178384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]